The decision by the United States to introduce 100% tariffs on pharmaceutical products starting October 1 is emerging as one of the most serious challenges for Germany and Europe in recent years. The move is viewed not only as a blow to European manufacturers’ economic interests but also as a threat to the stability of the global healthcare system.
BY DMITRY SUDAKOV
USA Readies to Crush European Pharmaceutical Industry